List of bibliographic references indexed by drug
Number of relevant bibliographic references: 63.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000055 (2017) |
Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil] | Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype. |
| 000121 (2017) |
Elisabet Jakova [Canada] ; Jeremy S. Lee [Canada] | Behavior of α-synuclein-drug complexes during nanopore analysis with a superimposed AC field. |
| 000351 (2016) |
Li-Li Zhang ; S. Duff Canning [Canada] ; Xiao-Ping Wang | Freezing of Gait in Parkinsonism and its Potential Drug Treatment |
| 000453 (2016) |
Juan Li [République populaire de Chine] ; Mohammadali Darabi [Canada] ; Jingjing Gu [République populaire de Chine] ; Junbin Shi [Canada] ; Jinhua Xue [République populaire de Chine] ; Lu Huang [République populaire de Chine] ; Yutong Liu [République populaire de Chine] ; Lei Zhang [République populaire de Chine] ; N. Liu [République populaire de Chine] ; Wen Zhong [Canada] ; Lin Zhang [République populaire de Chine] ; Malcolm Xing [Canada] ; Lu Zhang [République populaire de Chine] | A drug delivery hydrogel system based on activin B for Parkinson's disease. |
| 000483 (2015) |
James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel Krewski | Trends in inpatient antiparkinson drug use in the USA, 2001–2012 |
| 000809 (2015) |
Jonathan P. Wong [Canada] ; Paul Ditullio [États-Unis] ; Steve Parkinson [États-Unis] | Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria. |
| 000937 (2014) |
Donald A. Mcafee [Canada] ; Jonathan Hadgraft [Royaume-Uni] ; Majella E. Lane [Royaume-Uni] | Rotigotine: the first new chemical entity for transdermal drug delivery. |
| 000A55 (2014) |
Jocelyn M. Madeira [Canada] ; Ekta Bajwa [Canada] ; Maegan J. Stuart [Canada] ; Sadayuki Hashioka [Japon] ; Andis Klegeris [Canada] | Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst. |
| 000D92 (2013) |
Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] ; Christian Duval [Canada] | Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? |
| 000E82 (2013) |
Sharon Miksys ; Rachel F. Tyndale | 2011 CCNP Heinz Lehmann Award paper: Cytochrome P450–mediated drug metabolism in the brain |
| 001100 (2012) |
Lise N. Munsie ; Ray Truant | The role of the cofilin-actin rod stress response in neurodegenerative diseases uncovers potential new drug targets |
| 001249 (2012) |
Barbara S. Connolly [Canada] ; Susan H. Fox | Drug treatments for the neuropsychiatric complications of Parkinson's disease. |
| 001267 (2012) |
Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. Rompré | Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study. |
| 001280 (2012) |
Connie Marras [Canada] ; Nathan Herrmann ; Geoffrey M. Anderson ; Hadas D. Fischer ; Xuesong Wang ; Paula A. Rochon | Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex. |
| 001392 (2012) |
Shengyan Liu [Canada] ; Lyndon Jones [Canada] ; Frank X. Gu [Canada] | Nanomaterials for Ocular Drug Delivery |
| 001541 (2012) |
Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada] | Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study |
| 001681 (2011) |
Lori-Ann R. Sacrey [Canada] ; Scott G. Travis ; Ian Q. Whishaw | Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task. |
| 001720 (2011) |
Benoit Carignan [Canada] ; Jean-François Daneault ; Christian Duval | Assessing drug-induced dyskinesia in the clinic, the laboratory and the natural environment of patients. |
| 001889 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 001953 (2011) |
Lori-Ann R. Sacrey [Canada] ; Scott G. Travis [Canada] ; Ian Q. Whishaw [Canada] | Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task |
| 001A14 (2010) |
S. K. Kalia [États-Unis, Canada] ; L. V. Kalia [États-Unis, Canada] ; P. J. Mclean [États-Unis] | Molecular Chaperones as Rational Drug Targets for Parkinson’s Disease Therapeutics |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= drug
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
